Serum level of soluble interleukin-2 receptor in patients with seasonal allergic rhinitis

Scandinavian Journal of Immunology

Volumn 45, Issue 3, 1997, Pages 315-321

  Ohashi, Y ^a   Tanaka, A ^a   Kakinoki, Y ^a   Ohno, Y ^a   Sakamoto, H ^a   Kato, A ^a   Masamoto, T ^a   Washio, Y ^a   Nakai, Y ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR; POLLEN ANTIGEN;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031043841     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-392.x     Document Type: Article

References (19)

1. Morgan DA, Ruscetti FW, Gallo RC. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 1976; 193:1007-8.
2. + T lymphocytes. J Immunol 1982;129:1076-9.
3. Farrar JJ, Benjamin WR, Hilfker ML et al. The biochemistry, biology and role of interleukin-2 in the induction of cytotoxicity T cell antibody-forming B cell responses. Immunol Rev 1982; 63:129-66.
4. Wladmann TA. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation. Environ Health Perspect 1987;75:11-15.
5. Robb RJ, Munck A, Smith KA. T cell growth factor receptors. Quantitation, specificity and biological relevance. J Exp Med 1981;154:1455-74.
6. Rubin LA, Kurman CC, Fritz ME et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985;135:3172-7.
7. Pui CH. Serum interleukin-2 receptor: clinical and biological implications. Leukemia 1989;3:323-7.
8. Kahaleh MB. Le Roy EC. Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration. Ann Inter Med 1989;110:446-50.
9. Balderas RS. Elevated titers of cell-free interleukin 2 receptor in serum of lupus mice. J Immunol 1987;139:1496-500.
10. Kay AB. T lymphocytes and their products in atopic allergy and asthma. Int Arch Allergy Appl Immunol 1991;94:189-93.
11. Corrigan CJ, Hartnell A, Kay AB. T lymphocyte activation in acute severe asthma. Lancet 1988;i:1129-32.
12. Ohashi Y, Nakai Y, Sakamoto H et al. Serum levels of soluble interleukin-2 receptor in patients with perennial allergic rhinitis during immunotherapy. Ann Allergy Asthma Immunol 1996; 77: 203-8.
13. Chilosi M, Semenzato G, Cetto G et al. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant α-interferon therapy on clinical parameters and natural killer in vitro activity. Blood 1987;70: 1530-5.
14. Matsumoto T, Miike T, Yamaguchi K et al. Serum levels of soluble IL-2 receptors, IL-4 and IgE-binding factors in childhood allergic diseases. Clin Exp Immunol 1991;85:288-92.
15. Brown PH, Crompton GK, Greening AP. Proinflammatory cytokines in acute asthma. Lancet 1991;338:590-3.
16. Corrigan CJ, Kay AB. CD4 T-lymphocyte activation in acute severe asthma. Am Rev Respir Dis 1990;141:970-7.
17. Guarnaccia S, Kurman CCK, Notarangelo LD et al. Serum soluble interleukin-2 receptor (IL-2R) in children with allergic disorders. Ann Allergy 1993;71:259-62.
18. Ohashi Y, Nakai Y, Kakinoki Y et al. Effect of immunotherapy on serum level of eosinophil cationic protein in seasonal allergic rhinitis. Clin Otolaryngol 1996;77:203-8
19. Hsieh KH, Wu LH. Decreased expression of high affinity interleukin 2 receptors after hyposensitization to house dust. Ann Allergy 1987;59:57-62.